Cancer and pediatric inflammatory bowel disease

Seminars in Pediatric Surgery

Volumn 16, Issue 3, 2007, Pages 205-213

  Kayton, Mark L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer; Crohn's disease; Inflammatory bowel disease; Lymphoma; Pediatric; Transplant; Ulcerative colitis

Indexed keywords

FOLIC ACID; MESALAZINE; SALAZOSULFAPYRIDINE; URSODEOXYCHOLIC ACID;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CHILD; CHILDHOOD CANCER; DISEASE ASSOCIATION; ENTERITIS; HUMAN; KAPOSI SARCOMA; LONG TERM CARE; LYMPHOMA; MELANOMA; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL INTESTINE TUMOR; SQUAMOUS CELL CARCINOMA; ULCERATIVE COLITIS;

ADENOCARCINOMA; CHILD; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTESTINAL NEOPLASMS; LYMPHOMA;

EID: 34250880740     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2007.04.010     Document Type: Article

References (96)

1. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
2. Farrokhyar F., Swarbrick E.T., and Irvine E.J. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 36 1 (2001) 2-15
3. Barton J.R., Gillon S., and Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 30 (1989) 618-622
4. Sivarajasingham N., Adams S.A., Smith M.E.F., et al. Perianal Hodgkin's lymphoma complicating Crohn's disease. Int J Colorectal Dis 18 2 (2003) 174-176
5. Hill D.A., Dehner L.P., Gow K.W., et al. Perianal rhabdomyosarcoma presenting as a perirectal abscess: a report of 11 cases. J Pediatr Surg 37 4 (2002) 576-581
6. Oberto C., Schwarz K.B., Zambidis E., et al. Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease. Dig Dis Sci 49 3 (2004) 434-437
7. Merino M.J., and Livolsi V.A. Small cell malignant tumors of childhood: clinically presenting as inflammatory bowel disease. Conn Med 43 10 (1979) 621-624
8. Maaravi Y., Wengrower D., and Leibowitz G. A unique presentation of lymphoma of the colon. J Clin Gastroenterol 17 1 (1993) 49-51
9. McCullough J.E., Kim C.H., and Banks P.M. Mantle zone lymphoma of the colon simulating diffuse inflammatory bowel disease. Dig Dis Sci 37 6 (1992) 934-938
10. Kapoor G., Albrecht R.J., Craver R., et al. Diffuse large cell lymphoma presenting as inflammatory bowel disease in an adolescent with ataxia telangiectasia. Leuk Res 20 11-12 (1996) 997-998
11. Codling B.W., Keighley M.R.B., and Slaney G. Hodgkin's disease complicating Crohn's colitis. Surgery 82 5 (1977) 625-628
12. Vanbockrijck M., Cabooter M., Casselman J., et al. Primary Hodgkin disease of the ileum complicating Crohn disease. Cancer 72 (1993) 1784-1789
13. Vincenzi B., Finolezzi E., Fossati C., et al. Unusual presentation of Hodgkin's disease mimicking inflammatory bowel disease. Leuk Lymphoma 42 3 (2001) 521-526
14. Nordenholtz K.E., Stowe S.P., Stormont J.M., et al. The cause of death in inflammatory bowel disease: a comparison of death certificates and hospital charts in Rochester, New York. Am J Gastroenterol 90 6 (1995) 927-932
15. Ekbom A., Helmick C.G., Zack M., et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterol 103 (1992) 954-960
16. Persson P.-G., Bernell O., Leijonmarck C.-E., et al. Survival and cause-specific mortality in inflammatory bowel disease: a population-based study. Gastroenterol 110 (1996) 1339-1345
17. Jess T., Loftus Jr. E.V., Harmsen W.S., et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 55 (2006) 1248-1254
18. Jess T., Loftus Jr. E.V., Velayos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130 (2006) 1039-1046
19. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 (2001) 854-862
20. Tiszlavicz L., Kapin M., Várkonyi A., et al. Adenocarcinoma of the colon developing on the basis of Crohn's disease in childhood. Eur J Pediatr 160 (2000) 168-172
21. Michener W.M., Gage R.P., Sauer W.G., et al. The prognosis of chronic ulcerative colitis in children. N Engl J Med 265 (1961) 1075-1079
22. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
23. Gillen C.D., Andrews H.A., Prior P., et al. Crohn's disease and colorectal cancer. Gut 35 (1994) 651-655
24. Askling J., Dickman P.W., Karlén P., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120 (2001) 1356-1362
25. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 323 (1990) 1228-1233
26. Ekbom A., Helmick C., Zack M., et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336 (1990) 357-359
27. Gumaste V., Sachar D.B., and Greenstein A.J. Benign and malignant colorectal strictures in ulcerative colitis. Gut 33 7 (1992) 938-941
28. Stahl T.J., Schoetz Jr. D.J., Roberts P.L., et al. Crohn's disease and carcinoma: increasing justification for surveillance?. Dis Colon Rectum 35 (1992) 850-856
29. Heuschen U.A., Hinz U., Allemeyer E.H., et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 120 (2001) 841-847
30. Broomé U., Löfberg R., Veress B., et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22 5 (1995) 1404-1408
31. Marchesa P., Lashner B.A., Lavery I.C., et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 92 8 (1997) 1285-1288
32. Shetty K., Rybicki L., Brzezinski A., et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 94 6 (1999) 1643-1649
33. Knechtle S.J., D'Alessandro A.M., Harms B.A., et al. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 118 4 (1995) 615-620
34. Loftus Jr. E.V., Aguilar H.I., Sandborn W.J., et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 27 3 (1998) 685-690
35. Vera A., Gunson B.K., Ussatoff V., et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 75 12 (2003) 1983-1988
36. Siegel C.A., and Sands B.E. Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis 12 6 (2006) 491-496
37. Choi P.M., Nugent F.W., Schoetz Jr. D.J., et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105 (1993) 418-424
38. Collins P.D., Mpofu C., Watson A.J., et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2 (2006) CD000279
39. Eaden J.A., and Mayberry J.F. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51 suppl V (2002) v10-v12
40. Bernstein C.N., Shanahan F., and Weinstein W.M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 343 (1994) 71-74
41. Itzkowitz S.H. Cancer prevention in patients with inflammatory bowel disease. Gastroenterol Clin North Am 31 (2002) 1133-1144
42. Sarigol S., Wyllie R., Gramlich T., et al. Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr 28 4 (1999) 429-434
43. Remzi F.H., Fazio V.W., Delaney C.P., et al. Dysplasia of the anal transition zone after ileal pouch-anal anastomosis. Dis Colon Rectum 46 (2003) 6-13
44. Ejderhamn J., Rafter J.J., and Strandvik B. Faecal bile acid excretion in children with inflammatory bowel diseaes. Gut 32 (1991) 1346-1351
45. Tung B.Y., Emond M.J., Haggitt R.C., et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 134 (2001) 89-95
46. Pardi D.S., Loftus Jr. E.V., Kremers W.K., et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124 (2003) 889-893
47. Sjöqvist U., Tribukait B., Öst Á., et al. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study. Anticancer Res 24 (2004) 3121-3128
48. Reinacher-Schick A., Schoeneck A., Graeven U., et al. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis 24 3 (2003) 443-451
49. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14 (2000) 145-153
50. van Staa T.P., Card T., Logan R.F., et al. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 54 (2005) 1573-1578
51. Bernstein C.N., Blanchard J.F., Metge C., et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?. Am J Gastroenterol 98 (2003) 2784-2788
52. Terdiman J.P., Steinbuch M., Blumenthals W.A., et al. 5-Aminosalicylic acid therapy and the risk of colrectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 1-5
53. Freudenheim J.L., Graham S., Marshall J.R., et al. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 20 2 (1991) 368-374
54. Persson P.-G., Karlén P., Bernell O., et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterol 107 (1994) 1675-1679
55. Munkhold P., Langholz E., Davidsen M., et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 105 (1993) 1716-1723
56. Lashner B.A. Risk factors for small bowel cancer in Crohn's disease. Dig Dis Sci 37 8 (1992) 1179-1184
57. Henderson R.G., Long P.J., Al-Nafussi A.I., et al. Paget's disease with benign osteopetrosis and Crohn's disease. J R Soc Med 78 9 (1985) 766-768
58. Cameron E.M., Raeburn A., and Ford M.J. Neurofibromatosis and inflammatory bowel disease. Scott Med J 34 4 (1989) 500-501
59. Pfeffel F., Stiglbauer W., Depisch D., et al. Coincidence of Crohn's disease and a high-risk gastrointestinal stromal tumor of the terminal ileum. Digestion 60 (1999) 363-366
60. Mijandrušic Sinèic B., Kovac D., Jašic M., et al. Crohn's disease and a gastrointestinal stromal tumor in an 81-year-old man: a rare coincidence. Zentralbl Chir 130 (2005) 597-599
61. Laukhuf F., Tischer K.H., Strobel K., et al. Crohn's disease and stromal sarcoma of the small bowel: a rare coincidence. Z Gastroenterol 40 3 (2002) 193-196
62. Papadopoulos N., Goritsas C., Rontogianni D., et al. Coexistence of inflammatory bowel disease and gastrointestinal stromal tumor: a case report. Int J Intern Med 4 (2003) 7-9
63. Listinsky C.M., Halpern N.B., Workman R.B., et al. Ultrastructural and immunocytochemical features of a case of neuroendocrine carcinoma developing in a prior ileostomy site. Ultrastruct Pathol 18 5 (1994) 503-509
64. Le Marc'hadour F., Bost F., Peoc'h M., et al. Carcinoid tumour complicating inflammatory bowel disease. Pathol Res Pract 190 (1994) 1185-1192
65. Greenstein A.J., Balasubramanian S., Harpaz N., et al. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol 92 4 (1997) 682-685
66. Sigel J.E., and Goldblum J.R. Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases. Mod Pathol 11 6 (1998) 537-542
67. Israel K.J., and Nissenblatt M.J. Association of inflammatory bowel disease (IBD) with indolent soft-tissue sarcomas: report of two cases and review of literature. J Surg Oncol 32 2 (1986) 125-130
68. DiGiacomo J.C., Lazenby A.J., and Salloum L.J. Mesenteric fibromatosis associated with Crohn's disease. Am J Gastroenterol 89 7 (1994) 1103-1105
69. Slater G., and Greenstein A.J. Mesenteric fibromatosis in Crohn's disease. J Clin Gastroenterol 22 2 (1996) 147-149
70. Greenstein A.J., Sachar D.B., Shafir M., et al. Malignant melanoma in inflammatory bowel disease. Am J Gastroenterol 87 3 (1992) 317-320
71. Slater G., Greenstein A., and Aufses Jr. A.H. Anal carcinoma in patients with Crohn's disease. Ann Surg 199 3 (1984) 348-350
72. Kulaylat M.N., Doerr R., Butler B., et al. Squamous cell carcinoma complicating idiopathic inflammatory bowel disease. J Surg Oncol 59 1 (1995) 48-55
73. Frisch M., and Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer 83 1 (2000) 89-90
74. Greenstein A.J., Gennuso R., Sachar D.B., et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 56 (1985) 2914-2921
75. Ekbom A., Helmick C., Zack M., et al. Extracolonic malignancies in inflammatory bowel disease. Cancer 67 (1991) 2015-2019
76. Thompson G.B., Pemberton J.H., Morris S., et al. Kaposi's sarcoma of the colon in a young HIV-negative man with chronic ulcerative colitis. Dis Colon Rectum 32 1 (1989) 73-76
77. Puy-Montbrun T., Pigot F., Vuong P.N., et al. Kaposi's sarcoma of the colon in a young HIV-negative woman with Crohn's disease. Dig Dis Sci 36 4 (1991) 528-531
78. Koop H.O., Holodniy M., and List A.F. Fulminant Kaposi's sarcoma complicating long-term corticosteroid therapy. Am J Med 83 4 (1987) 787-789
79. Tedesco M., Benevolo M., Frezza F., et al. Colorectal Kaposi's sarcoma in an HIV-negative male in association with ulcerative rectocolitis: a case report. Anticanc Res 19 (1999) 3045-3048
80. Cohen R.L., Tepper R.E., Urmacher C., et al. Kaposi's sarcoma and cytomegaloviral ileocolitis complicating long-standing Crohn's disease in an HIV-negative patient. Am J Gastroenterol 96 (2001) 3028-3031
81. Bursics A., Morvay K., Ábrahám K., et al. HHV-8 positive, HIV negative disseminated Kaposi's sarcoma complicating steroid dependent ulcerative colitis: a successfully treated case. Gut 54 7 (2005) 1049-1050
82. Meltzer S.J., Rotterdam H.Z., and Korelitz B.I. Kaposi's sarcoma occurring in association with ulcerative colitis. Am J Gastroenterol 82 4 (1987) 378-381
83. Adlersberg R. Kaposi's sarcoma complicating ulcerative colitis: report of a case. Am J Clin Pathol 54 1 (1970) 143-146
84. Gordon H.W., and Rywlin A.M. Kaposi's sarcoma of the large intestine associated with ulcerative colitis. Gastroenterology 50 2 (1966) 248-253
85. Mackey A.C., Green L., Liang L.-C., et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44 (2007) 265-267
86. Ljung T., Karlén P., Schmidt D., et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 53 (2004) 849-853
87. Sandborn W.J., and Loftus E.V. Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease. Gut 53 (2004) 780-782
88. Lewis J.D., Bilker W.B., Brensinger C., et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121 (2001) 1080-1087
89. Loftus Jr. E.V., Tremaine W.J., Habermann T.M., et al. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 95 (2000) 2308-2312
90. Askling J., Brandt L., Lapidus A., et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54 (2005) 617-622
91. Kandiel A., Fraser A.G., Korelitz B.I., et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54 (2005) 1121-1125
92. Sonwalkar S.A., James R.M., Ahmad T., et al. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 52 (2003) 1518-1521
93. Sklar C., Boulad F., Small T., et al. Endocrine complications of pediatric stem cell transplantation. Front Biosci 6 (2001) g17-g22
94. Ditschkowski M., Einsele H., Schwerdtfeger R., et al. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation 75 10 (2003) 1745-1747
95. Oyama Y., Craig R.M., Traynor A.E., et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 128 (2005) 552-563
96. Itzkowitz S.H., and Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11 3 (2005) 314-321